j.jaci.2017.04.005

Factor XIIIa Antibody Summary

    Immunogen
    Recombinant protein corresponding to subunit-A of coagulation Factor XIIIa.
    Marker
    Dendritic Cell Marker
    Specificity
    This reacts with the 160 kDa (unreacted dimer) and 80 kDa (reduced monomer) protein.
    Isotype
    IgG
    Clonality
    Polyclonal
    Host
    Rabbit
    Gene
    F13A1
    Purity
    IgG purified
    Innovators Reward
    Test in a species/application not listed above to receive a full credit towards a future purchase.

    Learn about the Innovators Reward

Applications/Dilutions

    Dilutions
        Immunohistochemistry
        Immunohistochemistry-Paraffin
    Application Notes
    Optimal dilutions / concentrations should be determined by the end user.For formalin fixed paraffin embedded sections, perform heat mediated antigen retrieval using 10mM citrate buffer pH 6.0 before commencing with the IHC staining protocol.

Reactivity Notes

Cross-reacts with Human. Not yet tested in other species.

Packaging, Storage & Formulations

    Storage
    Store at 4C. Do not freeze.
    Buffer
    PBS
    Preservative
    Sodium Azide
    Purity
    IgG purified

Alternate Names for Factor XIIIa Antibody

      bA525O21.1 (coagulation factor XIII, A1 polypeptide)
      coagulation factor XIII A chain
      coagulation factor XIII, A1 polypeptide
      Coagulation factor XIIIa
      EC 2.3.2.13
      F13Acoagulation factor XIII, A polypeptide
      factor XIIIa
      fibrin stabilizing factor, A subunit
      fibrinoligase
      FSF, A subunit
      Protein-glutamine gamma-glutamyltransferase A chain
      TGase
      Transglutaminase A chain
      transglutaminase. plasma

Background

Factor XIII is a beta-globulin found in plasma and is composed of two subunits. It is the catalytic subunit and is a dimer of M.W. 160 kDa. Factor XIII is a dermal dendrocyte marker and shows variable reaction with these types of tumors. Factor XIII can be used for histiocytic phenotyping and has been reported to mark capillary hemangiomas and tumors of the central nervous system.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Letermovir

Related Post